---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-016081"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T02:22:59.570890+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics enters $3.85M ATM equity offering agreement with H.C. Wainwright

## Summary
- Company entered ATM offering agreement with H.C. Wainwright for up to $3,850,000 in common stock sales.
- Manager receives 3.0% commission on gross proceeds; Company provides customary indemnification and contribution rights.
- Offering is 'at the market' under Rule 415; Company may sell shares at its discretion over time.
- Agreement terminates upon sale of all shares or earlier termination by either party on specified prior notice.

## SEC filing metadata
- accession: 0001437749-24-016081
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/0001437749-24-016081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/atxi20240510_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-016081
- JSON: https://secwatch.observer/filing/0001437749-24-016081.json
- Plain text: https://secwatch.observer/filing/0001437749-24-016081.txt

## Key facts
- Material Agreements
  AVENUE THERAPEUTICS, INC. entered into At the Market Offering Agreement with H.C. Wainwright & Co. LLC valued at $3,850,000 (effective 2024-05-10).
  - Action: entry
  - Agreement: atm program
  - Counterparty: H.C. Wainwright & Co. LLC
  - Value: $3,850,000
  - Effective: 2024-05-10
  source text: On May 10, 2024, Avenue Therapeutics, Inc. (the “ Company ”) entered into an At the Market Offering Agreement (the “ Offering Agreement ”) with H.C. Wainwright & Co. LLC (the “ Manager ”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/0001437749-24-016081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.